Safety and efficacy of peptide receptor radionuclide therapy in treating high-risk patients with extensive neuroendocrine tumors

被引：0
|
作者：
Alsadik, S. R. [1 ]
Gnanasegaran, G. [1 ]
Chen, L. [1 ]
Toumpanakis, C. [1 ]
Caplin, M. [1 ]
Navalkissoor, S. [1 ]
机构：
[1] Royal Free Hosp, London, England
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷
关键词：
neuroendocrine tumor; net; peptide receptor radionuclide therapy prrt; 1771u-dotatate; extensive liver metastases; extensive skeletal metastases; extensive tumor burden;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K05
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [31] Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
    L. Bodei
    M. Kidd
    I. M. Modlin
    S. Severi
    I. Drozdov
    S. Nicolini
    D. J. Kwekkeboom
    E. P. Krenning
    R. P. Baum
    G. Paganelli
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 839 - 851
  • [32] Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience
    Vukomanovic, Vladimir
    Nedic, Katarina Vuleta
    Radojevic, Marija Zivkovic
    Dagovic, Aleksandar
    Milosavljevic, Neda
    Markovic, Marina
    Ignjatovic, Vladimir
    Vukomanovic, Ivana Simic
    Djukic, Svetlana
    Sreckovic, Marijana
    Backovic, Milena
    Vuleta, Marko
    Djukic, Aleksandar
    Vukicevic, Verica
    Ignjatovic, Vesna
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [33] Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
    Paolo Zanotti-Fregonara
    Clément Morgat
    Christophe Champion
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1095 - 1096
  • [34] Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)
    Baum, Richard P.
    Wang, Peipei
    Jakobsson, Vivianne
    Zhao, Tianzhi
    Schuchardt, Christiane
    Khong, Pek-Lan
    Zhang, Jingjing
    THERANOSTICS, 2024, 14 (01): : 133 - 142
  • [35] Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
    Bodei, L.
    Kidd, M.
    Modlin, I. M.
    Severi, S.
    Drozdov, I.
    Nicolini, S.
    Kwekkeboom, D. J.
    Krenning, E. P.
    Baum, R. P.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (05) : 839 - 851
  • [36] Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy
    Nguyen, C
    Faraggi, M
    Giraudet, AL
    de Labriolle-Vaylet, C
    Aparicio, T
    Rouzet, F
    Mignon, M
    Askienazy, S
    Sobhani, I
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (10) : 1660 - 1668
  • [37] Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE
    Pretot, Dominique
    Engel-Bicik, Ivette
    Kenkel, David
    Kaufmann, Philipp A.
    Treyer, Valerie
    Siebenhuner, Alexander R.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1204 - 1217
  • [38] Cardiac Metastases of Neuroendocrine Tumors Treated With 177Lu DOTATATE Peptide Receptor Radionuclide Therapy or 131I-MIBG Therapy
    Makis, William
    McCann, Karey
    Bryanton, Mark
    McEwan, Alexander J. B.
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (12) : 962 - 964
  • [39] Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting
    Kalshetty, Ashwini
    Ramaswamy, Anant
    Ostwal, Vikas
    Basu, Sandip
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1143 - 1149
  • [40] Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
    Moraitis, Alexandros
    Jentzen, Walter
    Costa, Pedro Fragoso
    Kersting, David
    Himmen, Stephan
    Coelho, Marta
    Meckel, Marian
    van Echteld, Cees J. A.
    Fendler, Wolfgang P.
    Herrmann, Ken
    Sraieb, Miriam
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (06) : 931 - 937
12345